BillionToOne, a precision diagnostics company, raised a $130 millionSeries D, valuing it at more than $1 billion, CEO Oguzhan Atay tells Axios exclusively.
Why it matters: The up-round comes on the heels of competitor Tempus AI's successful IPO debut last week.
